← Leaderboards
Robert Lunsford
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsAcuteClinical TrialsToxicologyFormulationPreclinical DevelopmentBrainLeadAdme StudySymptomsAnimal ModelPre-ClinicalReceptorConsumptionCnr1 GeneAuditory HallucinationAnxietyAcute SymptomEmergency CareCannabisCannabinoidsCannabinoid ReceptorChronicClinical Material
Grant awards (5)
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$5,192,092
ZIA · FY2021 · TR · contact PI
Development of Drinabant for Treatment of Acute Cannabinoid Overdose$1,071,030
ZIA · FY2021 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$1,071,030
ZIA · FY2021 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$1,071,030
ZIA · FY2021 · TR · contact PI
Development of Drinabant for Treatment of Acute Cannabinoid Overdose$1,723,640
ZIA · FY2020 · TR · contact PI